Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium
ELEVATE and ELECTRA studies were designed with the objective to overcome different treatment resistance mechanisms and enhance patient outcomes with oral-oral combination options. A preliminary analysis of data in the phase 1b part of the ELEVATE trial demonstrates antitumor activity...
STRADVISION CTO, Jack Sim, Unveils Innovative Deep Learning Development Methodology at Tech.AD USA 2023
Efficient Deep Learning: CTO Jack Sim unveils a streamlined development process through teacher-student learning and sprints Swift Product Releases: Reduces development time by 50%, enabling rapid creation of ImmersiView™ and monthly software releases Adaptable 3D Perception: The methodology extends to...
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation in Australia’s BreastScreen NSW Machine Reading Solution Project SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and...
CLASS101 Joins Forces with MarqVision in a Pioneering Partnership to Safeguard the Intellectual Property of Its Creators
SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ — CLASS101 (CEO Daisun Kong), South Korea’s top online learning platform, today announced that it has entered into an industry-pioneering partnership with MarqVision. In joining forces with MarqVision, the world’s first AI-powered Growth Protection...
BlackBerry Appoints John Giamatteo as CEO
Company to Pursue Full Separation of IoT and Cybersecurity Business Units Industry veteran Giamatteo to lead BlackBerry as Chief Executive Officer IoT and Cybersecurity business units to become fully standalone BlackBerry divisions Process underway to separate centralized functions and right-size...
"K-Beauty Tech Shines in the U.S." APR Corp. to Showcase Beauty Device Technology at CES 2024
The world’s largest IT-Home Appliance Trade Show, "CES 2024" in Las Vegas, Nevada. APR Corps will participate under the category of ‘lifestyle’ First participation ever since its establishment Plans to reveal new products for U.S. launch in addition to currently...
Global Times: Over 12,000 artifacts excavated from Sanxingdui Ruins site as latest achievements of civilization-tracing project revealed
BEIJING, Dec. 11, 2023 /PRNewswire/ — Chinese cultural authorities unveiled its latest archaeological achievements of the national project to trace the origins of Chinese civilization in Beijing on Saturday. Among the noteworthy breakthroughs is the preliminary understanding of the distribution and...
Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East
SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — Keppel Corporation Limited (Keppel), through its Infrastructure Division, and AM Green, which is wholly owned and controlled by the founders of Hyderabad-based Greenko Group, have signed a Memorandum of Understanding (MOU)...
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ — Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately. Piers Ingram,...
Xinhua Silk Road: Resilient power services of State Grid Jiangsu branch enable villages to tell new rural vitalization stories
BEIJING, Dec. 11, 2023 /PRNewswire/ — State Grid Jiangsu Electronic Power, a backbone power firm in east China’s Jiangsu Province, is enabling local villages to foster green rural vitalization with resilient power supply and related digital services. From November 27 to...
Vantage Markets Clinches Triple Victory at the 2023 Professional Trader Awards
PORT VILA, Vanuatu, Dec. 11, 2023 /PRNewswire/ — Multi-asset broker, Vantage (or Vantage Markets), is honoured to announce it has received three prestigious accolades at the 2023 Professional Trader Awards, reaffirming its standing as a leading broker for professional traders....
Azentio Software wins double honours at IBSi Global FinTech Innovation Awards 2023
Awards recognize ‘Impact-Generating Implementations’ at Summit Bank, Pakistan and Vision Bank, UAE SINGAPORE, Dec. 11, 2023 /PRNewswire/ — Azentio Software ("Azentio"), a Singapore-headquartered technology firm owned by funds advised by Apax Partners, today announced that it won two awards at the...
GCL SI Makes Waves at COP28, Showcasing Strong Commitment to Triple Renewable Energy Capacity
DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — The critical 28th United Nations Climate Change Conference, or Conference of Parties (COP28) is currently taking place in Dubai, bringing together global leaders and companies to take decisive action against climate change. As a...
Redefining Reliability, Geberit Extends Spare Parts Availability to 50 Years for Concealed Cisterns and Actuator Plates
SINGAPORE, Dec. 11, 2023 /PRNewswire/ — Geberit, a leading provider of sanitary products and systems, unveiled a guarantee for 50 years of spare parts availability for all replaceable mechanical components of their concealed cisterns, including the actuator plate, earlier this year....
The 2023 Forbes China Jiefangbei Forum: Chongqing's Rising Global Competitiveness and Urban Innovation
CHONGQING, China, Dec. 11, 2023 /PRNewswire/ — The 2023 Forbes China Jiefangbei Forum convened on November 28th at InterContinental Chongqing Raffles City in Chongqing’s Yuzhong District. Jointly hosted by Forbes China Group, the Chongqing Municipal Commission of Commerce, and the...
Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
The Phase I PERFORM trial, taking place at four clinical trial centers across the U.S., will evaluate the safety and preliminary efficacy of ATG-031 in patients with advanced solid tumors or B-cell non-Hodgkin’s lymphoma (B-NHL). ATG-031, discovered and developed in-house...